TREA

97450249 - WHAT PUTS THE ME IN MEDICAGO

Follow

Information

  • Trademark
  • 97450249
  • Serial Number
    97450249
  • Filing Date
    June 09, 2022
    2 years ago
  • Transaction Date
    December 06, 2023
    6 months ago
  • Status Date
    December 06, 2023
    6 months ago
  • Location Date
    December 06, 2023
    6 months ago
  • Status Code
    653
  • Current Location
    TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    WERT, KARL ANTHONY
  • Attorney Docket Number
    SWA0597TUS
    Attorney Name
    Benjamin M. Cantor
    Law Office Assigned Location Code
    N20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
WHAT PUTS THE ME IN MEDICAGO
Case File Statements
  • GS0401: Manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies
  • GS0051: Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancer
  • GS0441: Medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies
  • GS0421: Research and development in the field of human vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates
Case File Event Statements
  • 12/6/2023 - 6 months ago
    17 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 12/6/2023 - 6 months ago
    16 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 12/6/2023 - 6 months ago
    15 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 12/6/2023 - 6 months ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/6/2023 - 6 months ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/6/2023 - 6 months ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 7/6/2023 - 12 months ago
    11 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 4/6/2023 - a year ago
    10 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 4/6/2023 - a year ago
    9 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 4/6/2023 - a year ago
    8 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 3/29/2023 - a year ago
    7 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 8/23/2022 - a year ago
    6 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 8/23/2022 - a year ago
    5 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 8/23/2022 - a year ago
    4 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 8/19/2022 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/21/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/13/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP